OPTI Optibiotix Health Plc

TIDMOPTI

OptiBiotix Health PLC

09 October 2020

Opti B i otix Health plc

( "Opti Bi o t ix")

Investor presentation

OptiBi otix Health p lc (AI M : OPTI), a life sciences busi ness d e vel o ping co m p o u n ds to tack le o besit y, high choleste r ol and diabetes, announces that Stephen O'Hara, Chief Executive, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox Markets.

The event will be held on Thursday, 15 October 2020 at 2pm. To access the event, please register your interest at https://voxmarkets.brand.live/c/optibiotix-health-plc-investor-presentation

No new price-sensitive information will be disclosed as part of the presentation.

 
 OptiBiotix Health plc                                          www.optibiotix.com 
 Stephen O'Hara, Chief Executive                              Contact via Walbrook 
                                                                             below 
 
 Walbrook PR Ltd                   Tel: 020 7933 8780 or optibiotix@walbrookpr.com 
 Anna Dunphy                                                    Mob: 07876 741 001 
 
 

About OptiBiotix - www.optibiotix.com

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than sixty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products. The current areas of focus for the business include obesity, cardiovascular health, diabetes, digestive health, and health and wellbeing.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAUPGWWUUPUGPB

(END) Dow Jones Newswires

October 09, 2020 09:00 ET (13:00 GMT)

Optibiotix Health (LSE:OPTI)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Optibiotix Health (LSE:OPTI)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024